Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.58%
SPX
+0.03%
IXIC
+0.28%
FTSE
-0.07%
N225
+0.29%
AXJO
+0.13%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
Health Care
iobt
IO Biotech
NASDAQ: IOBT
-0.11 (-22.75%)
0.3708
USD
At close at Jan 23, 21:45 UTC
Summary
News
Signals
Benchmarks
Financials

Overview

Loading chart...

Key Stats

Market Cap
31.62M
Dividend Yield
0.00%
P/E Ratio
-0.36
EPS
-1.49
Revenue
-
Avg. Volume
127.90M

Recently from Cashu

No Cashu articles
IO Biotech currently has no Cashu-related articles

About

What does IOBT do?
IO Biotech develops immune-modulating cancer therapies using its Twin technology platform, targeting tumor-induced immunosuppression. Its lead candidate, IO102-IO103, addresses key proteins IDO and PD-L1.
Sector
💻 Health Care
IPO
CEO
Employees
80
Headquarters
Denmark
Website
https://www.iobiotech.com
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.